Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.6211 | 26 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.57513 | 25 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.57951 | 25 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.48875 | 23 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.52761 | 25 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.632 | 24 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.5916 | 24 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.54405 | 24 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.55259 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.57796 | 26 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.5598 | 25 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.51479 | 23 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.5754 | 25 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.56614 | 25 |